Literature DB >> 13171805

Studies on the effect of probenecid (benemid) in gout.

R M MASON.   

Abstract

Entities:  

Keywords:  GOUT/therapy; PROBENECID/therapeutic use

Mesh：

Substances：

Year:  1954        PMID： 13171805      PMCID： PMC1030399          DOI： 10.1136/ard.13.2.120

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  19 in total

1.  Studies in gout, with particular reference to the value of sodium salicylate in treatment.

Authors:  F G MARSON
Journal:  Q J Med       Date:  1953-07

2.  Primary and secondary gout.

Authors:  A B GUTMAN
Journal:  Ann Intern Med       Date:  1953-11       Impact factor: 25.391

3.  SERUM URATE IN RELATIVES OF GOUTY PATIENTS.

Authors:  J H Talbott
Journal:  J Clin Invest       Date:  1940-07       Impact factor: 14.808

4.  Mobilization of gouty tophi by protracted use of uricosuric agents.

Authors:  T F YU; A B GUTMAN
Journal:  Am J Med       Date:  1951-12       Impact factor: 4.965

5.  The clinical and metabolic effects of benemid in patients with gout.

Authors:  J H TALBOTT; C BISHOP; B M NORCROSS; L M LOCKIE
Journal:  Trans Assoc Am Physicians       Date:  1951

6.  The effect of benemid (P-[DI-N-propylsulfamyl]-benzoic acid) on uric acid metabolism in one normal and one gouty subject.

Authors:  C BISHOP; R RAND; J H TALBOTT
Journal:  J Clin Invest       Date:  1951-08       Impact factor: 14.808

7.  Blood flow in gout.

Authors:  A J BARNETT
Journal:  Br Med J       Date:  1951-04-07

8.  ACTH and colchicine in the clinical treatment of acute gouty arthritis; physiological considerations and review of therapeutic results in 51 attacks.

Authors:  W Q WOLFSON; H D HUNT; C COHN; W D ROBINSON; I F DUFF
Journal:  J Mich State Med Soc       Date:  1950-09

9.  The clinical usefulness of ACTH and cortisone.

Authors:  G W THORNE; P H FORSHAM; T F FRAWLEY; S R HILL; M ROCHE; D STAEHELIN; D L WILSON
Journal:  N Engl J Med       Date:  1950-05-25       Impact factor: 91.245

10.  Metabolic studies in gout with emphasis on the role of electrolytes in acute gouty arthritis.

Authors:  M H LEVIN; J B RIVO; S H BASSETT
Journal:  Am J Med       Date:  1953-10       Impact factor: 4.965
View more
  8 in total

1.  GOUT.

Authors: 
Journal:  Br Med J       Date:  1958-03-29

2.  Diet and alcohol in gout.

Authors: 
Journal:  Br Med J       Date:  1967-09-02

3.  Probenecid protects against transient focal cerebral ischemic injury by inhibiting HMGB1 release and attenuating AQP4 expression in mice.

Authors:  Xiao-Xing Xiong; Li-Juan Gu; Jian Shen; Xian-Hui Kang; Yue-Ying Zheng; Si-Biao Yue; Sheng-Mei Zhu
Journal:  Neurochem Res       Date:  2013-12-07       Impact factor: 3.996

4.  Synthesis, X-ray diffraction analysis, quantum chemical studies and α-amylase inhibition of probenecid derived S-alkylphthalimide-oxadiazole-benzenesulfonamide hybrids.

Authors:  Bilal Ahmad Khan; Syeda Shamila Hamdani; Muhammad Naeem Ahmed; Shahid Hameed; Muhammad Ashfaq; Ahmed M Shawky; Mahmoud A A Ibrahim; Peter A Sidhom
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

Review 5.  Efficacy and safety of urate-lowering therapy in people with kidney impairment: a GCAN-initiated literature review.

Authors:  Hamish Farquhar; Ana B Vargas-Santos; Huai Leng Pisaniello; Mark Fisher; Catherine Hill; Angelo L Gaffo; Lisa K Stamp
Journal:  Rheumatol Adv Pract       Date:  2021-01-04

6.  Association Between Use of Anti-gout Preparations and Dementia: Nested Case-Control Nationwide Population-Based Cohort Study.

Authors:  Tsung-Ju Chuang; Yu-Hsun Wang; James Cheng-Chung Wei; Chih-Jung Yeh
Journal:  Front Med (Lausanne)       Date:  2021-01-12

7.  Reporter dyes demonstrate functional expression of multidrug resistance proteins in the marine flatworm Macrostomum lignano: the sponge-derived dye Ageladine A is not a substrate of these transporters.

Authors:  Kristin Tietje; Georgina Rivera-Ingraham; Charlotte Petters; Doris Abele; Ralf Dringen; Ulf Bickmeyer
Journal:  Mar Drugs       Date:  2013-10-16       Impact factor: 5.118

8.  N-Butyrylated hyaluronic acid ameliorates gout and hyperuricemia in animal models.

Authors:  Lanzhou Li; Di Wang; Xueju Wang; Ruifeng Bai; Chunyu Wang; Yin Gao; Tassos Anastassiades
Journal:  Pharm Biol       Date:  2019-12       Impact factor: 3.503
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.